Ganas Ventures
VC firmGanas Ventures is a Latina-led venture capital firm investing in pre-seed and seed-stage, community-driven startups across the United States and Latin America. They focus on diverse founders addressing significant challenges in growing markets, aiming to create generational wealth through community engagement.
Founded in 2022 by General Partner Lolita Taub, Ganas Ventures has invested in over 20 companies, with a portfolio that includes 90% BIPOC-led, 50% Latine-led, 55% women-led, and 10% LGBTQ-led companies. The firm offers support beyond capital, providing access to a community of over 86,000 members, 70 limited partners, and 100 deal partners to help portfolio companies succeed.
Specification
Stages
1. Idea or Patent
2. Prototype
3. Early Revenue
4. Scaling
Target countries
Lead
N/A
Tickets
$100k to $100k
Location
San Diego, California, Argentina
Explore similar Venture Funds to Ganas Ventures
We invest in Artificial Intelligence, Machine Intelligence & IoT, as we rapidly see hardware and software products coming together using artif...
Specification
Target countries
Stages
1. Idea or Patent
2. Prototype
+ 1
We invest in B2B SaaS. High Alpha is an Indianapolis-based venture studio, focusing on company creation and scale in the B2B SaaS space. High Alpha...
Specification
Target countries
Stages
3. Early Revenue
4. Scaling
We invest in pre-seed to seed stage, blockchain, crypto, and web3 startups. We seek companies early, under $25M in valuation.
Specification
Target countries
Stages
1. Idea or Patent
2. Prototype
+ 2
Our focus is on turning great founders into great leaders of growing startup ventures. We set goals with you at the beginning of the program with t...
Specification
Target countries
Stages
2. Prototype
3. Early Revenue
We invest in capital efficient entrepreneurs who are already generating revenue ($500k-$1M) who are solving deep societal problems that affects Hea...
Specification
Target countries
Stages
3. Early Revenue
We invest in creative biosciences – companies building new biology for applications in human health (therapeutics, diagnostics, and devices) ...
Specification
Target countries
Stages
3. Early Revenue
2. Prototype
+ 1